Dendritic cells with an increased PD-L1 by TGF-β induce T cell anergy for the cytotoxicity of hepatocellular carcinoma cells

International Immunopharmacology

Volumn 20, Issue 1, 2014, Pages 117-123

  Song, Shasha ^a   Yuan, Pingfan ^a   Wu, Huaxun ^a   Chen, Jingyu ^a   Fu, Jingjing ^a   Li, Peipei ^a   Lu, Jingtao ^a   Wei, Wei ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Cytotoxicity; Dendritic cells; Programmed death ligand 1; Signal transducers and activators of transcription 3; T cell anergy; Transforming growth factor

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; PROGRAMMED DEATH 1 LIGAND 1; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; CD274 PROTEIN, MOUSE; STAT3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CD4+ CD25+ FOXP3+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLONAL ANERGY; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; DOSE TIME EFFECT RELATION; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; ANIMAL; BAGG ALBINO MOUSE; CELL SURVIVAL; COCULTURE; IMMUNOLOGY; LIVER TUMOR; MALE; T LYMPHOCYTE; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD274; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL SURVIVAL; CLONAL ANERGY; COCULTURE TECHNIQUES; DENDRITIC CELLS; LIVER NEOPLASMS; MALE; MICE, INBRED BALB C; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 84896374641     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.02.027     Document Type: Article

References (31)

1. L. Apetoh, C. Locher, F. Ghiringhelli, G. Kroemer, and L. Zitvogel Harnessing dendritic cells in cancer Semin Immunol 31 2011 42 49
2. K. Palucka, H. Ueno, J. Fay, and J. Banchereau Dendritic cells and immunity against cancer J Intern Med 269 2011 64 73
3. C. Bergmann, L. Strauss, R. Zeidler, S. Lang, and T.L. Whiteside Expansion and characteristics of human T regulatory type 1 cells in co-cultures stimulating tumor microenvironment Cancer Immunol Immunother 56 2007 1429 1442 (Pubitemid 47024702)
4. + regulatory T cells J Leukoc Biol 92 2012 673 682
5. T. Chan, R.H. Wiltrout, and J.M. Weiss Immunotherapeutic modulation of the suppressive liver and tumor microenvironments Int Immunopharmacol 11 2011 879 889
6. T. Yi, X. Li, S. Yao, L. Wang, Y. Chen, and D. Zhao et al. Host APCs augment in vivo expansion of donor natural regulatory T cells via B7H1/B7.1 in allogeneic recipients J Immunol 11 2011 2739 2749
7. S.M. Bray, L. Vujanovic, and L.H. Butterfield Dendritic cell-based vaccines positively impact natural killer and regulatory T cells in hepatocellular carcinoma patients Clin. Dev. Immunol. 2011 2011 249281
8. T.L. Sumpter, and A.W. Thomson The status of PD-L1 (B7-H1) on tolerogenic APCs Eur J Immunol 41 2011 286 290
9. C. Brandl, S. Ortler, T. Herrmann, S. Cardell, M. Lutz, and H. Wiendl B7-H1-deficiency enhances the potential of tolerogenic dendritic cells by activating CD1d-restrict type IINKT cells PLoS One 5 2010 e10800
10. J.A. CY Huang, Y. Chen, C. Chen, and X.G. Zhang High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation Med Oncol 28 2011 682 688
11. + T cells EMBO Mol Med 3 2011 581 592
12. X. Zhou, Y. Zhou, Q. Ding, Z. Jiao, L. Lu, and N. Yang et al. High level expression of B7H1 molecules by keratinocytes suppresses xeno- and allo-reactions by inducing type I regulatory T cells Transpl Immunol 21 2009 192 197
13. L. Yang, and Y. Pang Mouse HL.TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression Trends Immunol 31 2010 220 227
14. + regulatory T cells Cell Mol Immunol 7 2010 35 43
15. X.Y. Ni, H.X. Sui, Y. Liu, S.Z. Ke, Y.N. Wang, and F.G. Gao TGF-β of lung cancer microenvironment upregulates B7-H1 and GITRL expression in dendritic cells and is associated with regulatory T cell generation Oncol Rep 28 2012 615 621
16. K. Sato, K. Eizumi, T. Fukaya, S. Fujita, Y. Sato, and H. Takagi et al. Naturally occurring regulatory dendritic cells regulate murine cutaneous chronic graft-versus-host disease Blood 113 2009 4780 4789
17. Q. Ruan, V. Kameswaran, Y. Tone, L. Li, H.C. Liou, and M.I. Greene et al. Development of Foxp3(+) regulatory T cells is driven by the c-Rel enhanceosome Immunity 31 2009 932 940
18. R.L. Sabado, and N. Bhardwaj Directing dendritic cell immunotherapy towards successful cancer treatment Immunotherapy 2 2010 37 56
19. Y. Qiu, M.B. Xu, M.M. Yun, Y.Z. Wang, R.M. Zhang, and X.K. Meng et al. Hepatocellular carcinoma-specific immunotherapy with synthesized α1, 3-galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells World J Gastroenterol 17 2011 5260 5266
20. U.K. Scarlett, M.R. Rutkowski, A.M. Rauwerdink, J. Fields, X. Escovar-Fadul, and J. Baird et al. Ovarian cancer progression is controlled by phenotypic changes in dendritic cells J Exp Med 209 2012 495 506
21. M. Marzec, Q. Zhang, A. Goradia, P.N. Raghunath, X. Liu, and M. Paessler et al. Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1) Proc Natl Acad Sci 105 2008 20852 20857
22. S.J. Wölfle, J. Strebovsky, H. Bartz, A. Sähr, C. Arnold, and C. Kaiser et al. PD-L1 expression on tolerogenic APCs is controlled by STAT-3 Eur J Immunol 41 2011 413 424
23. + cell population arising upon IL-10-driven maturation Oncoimmunology 2 2013 e23837
24. H. Yu, M. Kortylewski, and D. Pardoll Crosstalk between cancer and immune cells: role of STAT3 in the tumor microenvironment Nat Rev Immunol 7 2007 41 51 (Pubitemid 46020826)
25. G.B. Lesinski The potential for targeting the STAT3 pathway as a novel therapy for melanoma Future Oncol 9 2013 925 927
26. L. Lin, R. Amin, G.I. Gallicano, E. Glasgow, W. Jogunoori, and J.M. Jessup et al. The STAT3 inhibitor NSC74859 is effective in hepatocellular cancers with disrupted TGF-β signaling Oncogene 28 2009 961 972
27. B. Schreiner, S.L. Bailey, T. Shin, L. Chen, and S.D. Miller PD-1 ligands expressed on myeloid-derived APC in the CNS regulatory T-cell responses in EAE Eur J Immunol 38 2008 2706 2717
28. V.V. Parekh, S. Lalani, S. Kim, R. Halder, M. Azuma, and H. Yagita et al. PD-L1/PD-1 blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells J Immunol 182 2009 2816 2826
29. + T cells Oncoimmunology 2 2009 e23991
30. + Treg and liver tolerance induction in mice Transplant Proc 45 2013 1853 1855
31. M.H. Andersen PD-L1 expression in B-cell lymphomas and virus-associated malignancies Clin Cancer Res 19 2013 4017